Has Sadia Arshad, MD received payments from drug or device companies?

Yes. Drug and device makers reported $148 in general payments to Sadia Arshad, MD across 2 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sadia Arshad, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sadia Arshad, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sadia Arshad, MD

Rheumatology · Howard Beach, NYNPI 1841422516

Payments from drug & device makers

$148in general payments, 2019–2025

Across 2 payments — averaging $73.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Penumbra, Inc.$123
GSK$24

What the payments were for

Food & beverage$148100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Penumbra, Inc.	1	$123
GSK	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Indigo System$123

How this compares

$148 in reported general payments places this provider in the 15th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York →

Medicare billing

Part B allowed, 2024

$368,522

Medicare patients

156

Services billed

15,486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	33	$220,500
Enbrel SureclickEtanercept	14	$202,893
Humira PenAdalimumab	12	$76,625
ProliaDenosumab	11	$18,438
Azathioprine	63	$6,757
Leflunomide	77	$5,405
Hydroxychloroquine Sulfate	232	$5,367
Diclofenac Sodium	108	$4,124
MethotrexateMethotrexate Sodium	125	$1,929
Duloxetine Hcl	39	$1,398
Gabapentin	115	$1,155
Sulfasalazine	68	$1,090
Alendronate Sodium	138	$562
Febuxostat	17	$546
Clobetasol Propionate	15	$486

Paid to pharmacies, not to this prescriber.

Other rheumatology in Howard Beach

Amit SaxenaNew York$6.7M
Cynthia AranowManhasset$5.3M
Richard FurieNew Hyde Park$4.3M
Robert SpieraNew York$4.3M
David GoddardBrooklyn$3.9M
Laurie GlimcherNew York$3.9M
Anca AskanaseNew York$3.5M
Grace WrightNew York$3M
Jose ScherNew York$2.7M
Kostas BotsoglouCheektowaga$2.6M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →